Chong Kun Dang, Jinyang increase their collaboration for new premature ejaculation drug

Chong Kun Dang Pharmaceutical and Jinyang Pharmaceutical announced Monday that both companies has signed an agreement to extend their collaboration for Jinyang’s new premature ejaculation treatment containing clomipramine.

Under the contract, Jinyang officials said that Chong Kun Dang will exclusively start market the drug from July and their partnership will be extended for the next 10 year...